Literature DB >> 7918075

Protein C, antithrombin III and plasminogen: effect of age, sex and blood group.

G Dolan1, K Neal, P Cooper, P Brown, F E Preston.   

Abstract

We conducted a cross-sectional study of antithrombin III (ATIII), protein C (PC) and plasminogen (Plg) concentrations in a population of healthy plasma donors in the Trent Region. The distribution of values for protein C was log normal whereas for ATIII and Plg the distributions were positively skewed and differed significantly from normal and log normal. Males had higher antithrombin III concentrations (mean 1.10 iu/ml, range 0.72-1.65) than females (mean 1.07 iu/ml, range 0.75-1.69) (P = 0.001) and levels increased with age in women. Younger women aged 25-34 had significantly lower plasma concentrations of ATIII compared to males of similar age. For protein C, concentrations were higher in males (mean 1.07 u/ml, range 0.37-2.11) than in females (mean 1.01 u/ml, range 0.59-1.61) (P < 0.001) and levels increased with age in both sexes P < 0.001). In women, a novel difference in protein C concentration between ABO blood groups was noted. There was no significant difference in plasminogen concentration between males and females, and in women plasminogen decreased with age (r = -0.205, P < 0.001). We conclude that these variations in ATIII and protein C with age and sex are important considerations in the determination of reference ranges for these proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918075     DOI: 10.1111/j.1365-2141.1994.tb04832.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrums.

Authors:  Davide Capodanno; Dominick J Angiolillo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

Review 2.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

3.  Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Authors:  Tienan Zhu; Qiulan Ding; Xia Bai; Xiaoyan Wang; Florentia Kaguelidou; Corinne Alberti; Xuqian Wei; Baolai Hua; Renchi Yang; Xuefeng Wang; Zhaoyue Wang; Changgeng Ruan; Nicole Schlegel; Yongqiang Zhao
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

4.  [Intravitreal fibrinolysis and retinal vein occlusion].

Authors:  T Bertelmann; T Stief; W Sekundo; M Witteborn; S Strodthoff; S Mennel; N Nguyen; M Koss
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

5.  Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Authors:  N Rydz; J Grabell; D Lillicrap; P D James
Journal:  Haemophilia       Date:  2015-03-10       Impact factor: 4.287

Review 6.  Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.

Authors:  Dimitra Akrivou; Garifallia Perlepe; Paraskevi Kirgou; Konstantinos I Gourgoulianis; Foteini Malli
Journal:  Medicina (Kaunas)       Date:  2022-08-10       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.